复方磺胺甲噁唑预防与侵袭性肺炎球菌病的抗生素耐药性。
Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease.
机构信息
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
出版信息
Antimicrob Agents Chemother. 2012 Mar;56(3):1602-5. doi: 10.1128/AAC.05813-11. Epub 2012 Jan 9.
Abstract
Among 5,043 invasive pneumococcal disease (IPD) isolates identified through South African national surveillance from 2003 to 2007, we estimated the effect of trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis on antimicrobial resistance. Patients on TMP-SMX prophylaxis were more likely to have a pneumococcal isolate nonsusceptible to TMP-SMX, penicillin, and rifampin. TMP-SMX nonsusceptibility was associated with nonsusceptibility to penicillin, erythromycin, and rifampin and multidrug resistance. This study informs empirical treatment of suspected IPD in patients with a history of TMP-SMX use.
摘要
在南非国家监测系统 2003 至 2007 年间所确定的 5043 例侵袭性肺炎球菌病（IPD）分离株中，我们评估了复方磺胺甲噁唑（TMP-SMX）预防对药物耐药性的影响。接受 TMP-SMX 预防的患者其肺炎球菌分离株对 TMP-SMX、青霉素和利福平的耐药性更可能增加。TMP-SMX 耐药与青霉素、红霉素和利福平耐药以及耐多药有关。本研究为 TMP-SMX 使用史患者疑似 IPD 的经验性治疗提供了信息。
相似文献
1
Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease.
Antimicrob Agents Chemother. 2012 Mar;56(3):1602-5. doi: 10.1128/AAC.05813-11. Epub 2012 Jan 9.
2
Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
Clin Infect Dis. 2011 Oct;53(7):631-9. doi: 10.1093/cid/cir443.
3
Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: A multicenter retrospective study in mainland China.
Medicine (Baltimore). 2019 Jun;98(24):e15942. doi: 10.1097/MD.0000000000015942.
4
Increasing penicillin and trimethoprim-sulfamethoxazole resistance in nasopharyngeal Streptococcus pneumoniae isolates from Guatemalan children, 2001--2006.
Int J Infect Dis. 2008 May;12(3):289-97. doi: 10.1016/j.ijid.2007.09.001. Epub 2007 Nov 26.
5
Pneumococcal serotype distribution and antibiotic susceptibility in Malaysia: A four-year study (2014-2017) on invasive paediatric isolates.
Int J Infect Dis. 2019 Mar;80:129-133. doi: 10.1016/j.ijid.2018.12.009. Epub 2018 Dec 17.
6
Eleven-year surveillance of antibiotic resistance in Streptococcus pneumoniae in Casablanca (Morocco).
Microb Drug Resist. 2012 Apr;18(2):157-60. doi: 10.1089/mdr.2011.0130. Epub 2012 Jan 4.
7
Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
Int J Med Microbiol. 2015 Oct;305(7):776-83. doi: 10.1016/j.ijmm.2015.08.031. Epub 2015 Aug 22.
8
Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.
Antimicrob Agents Chemother. 2014 Jun;58(6):3293-305. doi: 10.1128/AAC.02580-13. Epub 2014 Mar 31.
9
Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
Pediatrics. 2003 Oct;112(4):862-9. doi: 10.1542/peds.112.4.862.
10
Predicting antimicrobial resistance in invasive pneumococcal infections.
Clin Infect Dis. 2005 May 1;40(9):1288-97. doi: 10.1086/429242. Epub 2005 Mar 31.
引用本文的文献
1
The characteristics and clinical course of patients with melioidosis and cancer.
PLoS Negl Trop Dis. 2024 Oct 25;18(10):e0012631. doi: 10.1371/journal.pntd.0012631. eCollection 2024 Oct.
2
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children.
Nat Commun. 2024 Sep 27;15(1):8401. doi: 10.1038/s41467-024-52459-3.
3
Asplenia and spleen hypofunction.
Nat Rev Dis Primers. 2022 Nov 3;8(1):71. doi: 10.1038/s41572-022-00399-x.
4
Serotypes and Vaccine Coverage of Colonization in the Nasopharynx of Thai Children in Congested Areas in Chiang Mai.
Pathogens. 2020 Nov 26;9(12):988. doi: 10.3390/pathogens9120988.
5
Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve human immunodeficiency virus-exposed infected and -uninfected South African children.
Medicine (Baltimore). 2020 Feb;99(9):e19353. doi: 10.1097/MD.0000000000019353.
6
The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Strains Isolated from Adults in Crete, Greece, 2009-2016.
Infect Chemother. 2018 Dec;50(4):328-339. doi: 10.3947/ic.2018.50.4.328.
7
COMMUNITY ACQUIRED PNEUMOCOCCAL PNEUMONIA IN NORTHWESTERN NIGERIA: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE AND OUTCOME.
Afr J Infect Dis. 2017 Nov 15;12(1):15-19. doi: 10.21010/ajid.v12i1.3. eCollection 2018.
8
Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
J Infect Dis. 2016 Oct 15;214(8):1243-51. doi: 10.1093/infdis/jiw338. Epub 2016 Jul 28.
9
HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
PLoS One. 2016 Feb 10;11(2):e0149104. doi: 10.1371/journal.pone.0149104. eCollection 2016.
10
Antimicrobial Susceptibility Pattern of Invasive Pneumococcal Isolates in North West Nigeria.
J Glob Infect Dis. 2015 Apr-Jun;7(2):70-4. doi: 10.4103/0974-777X.154440.
本文引用的文献
1
Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
Clin Infect Dis. 2011 Oct;53(7):631-9. doi: 10.1093/cid/cir443.
2
Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
AIDS. 2010 Jul 17;24(11):1709-16. doi: 10.1097/QAD.0b013e32833ac6bc.
3
Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Antimicrob Agents Chemother. 2008 Jul;52(7):2480-5. doi: 10.1128/AAC.01118-07. Epub 2008 Apr 28.
4
Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa.
J Infect. 2008 Mar;56(3):171-8. doi: 10.1016/j.jinf.2007.12.003. Epub 2008 Feb 8.
5
The role of antimicrobial use in the epidemiology of resistant pneumococci: A 10-year follow up.
Microb Drug Resist. 2006 Fall;12(3):169-76. doi: 10.1089/mdr.2006.12.169.
6
7
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Lancet. 2004;364(9448):1865-71. doi: 10.1016/S0140-6736(04)17442-4.
8
Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
Clin Infect Dis. 2004 Jun 1;38(11):1623-8. doi: 10.1086/420933. Epub 2004 May 12.
9
Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children.
Pediatr Infect Dis J. 2003 Jun;22(6):564-7.
10
The impact of HIV infection and trimethoprim-sulphamethoxazole prophylaxis on bacterial isolates from children with community-acquired pneumonia in South Africa.
J Trop Pediatr. 2003 Apr;49(2):78-83. doi: 10.1093/tropej/49.2.78.
Zotero 插件